Human medicines European public assessment report (EPAR): Pepaxti, melphalan flufenamide, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 January 2025 - 14:50

Human medicines European public assessment report (EPAR): Pepaxti, melphalan flufenamide, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/pepaxti

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters